ea0026p4 | Adrenal cortex | ECE2011
Luconi M
, Poli G
, Mangoni M
, Pezzati P
, Francalanci M
, Gelmini S
, Canu L
, Cantini G
, Serio M
, Mannelli M
Adrenocortical carcinoma (ACC) is a rare aggressive tumor with a poor prognosis. At present, early diagnosis followed by total surgical tumor resection is the only valuable option for ACC cure and mitotane (MTT) is the only specific drug available for pharmacological treatment. However, its effects seem to be mainly due to its adrenocortical cytotoxicity and its bioavailability and cellular mechanism of action are still unknown, making it difficult to develop less toxic multid...